Shanghai Hile Bio-Technology Co., Ltd. (SHA:603718)

Market Cap	4.46B
Revenue (ttm)	273.22M
Net Income (ttm)	174.29M
Shares Out	655.66M
EPS (ttm)	0.26
PE Ratio	25.69
Forward PE	n/a
Dividend	0.08 (1.15%)
Ex-Dividend Date	Jul 15, 2025

Volume	4,050,523
Average Volume	7,639,522
Open	6.81
Previous Close	6.81
Day's Range	6.77 - 6.83
52-Week Range	6.04 - 9.11
Beta	0.15
RSI	32.15
Earnings Date	Oct 30, 2025

About SHA:603718

Shanghai Hile Bio-Technology Co., Ltd. researches, develops, produces, and sells veterinary biological products for livestock and poultry in China. The company offers swine fever live vaccines; trivalent inactivated vaccines for piglets; and inactivated vaccine for streptococcus suis. It also provides inactivated avian infectious rhinitis vaccines; newcastle disease and avian influenza combined inactivated vaccines; newcastle disease, infectious bronchitis, egg drop syndrome, and avian influenza quadruple inactivated vaccines; avian influenza i...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1981
• Employees: 366
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603718

Financial Performance

In 2024, SHA:603718's revenue was 271.04 million, an increase of 12.59% compared to the previous year's 240.72 million. Earnings were 171.18 million, an increase of 172.28%.